Worsened Dysrhythmia after Chemical Cardioversion with Digoxin; a Case of Malpractice
Archives of Academic Emergency Medicine,
Vol. 2 No. 3 (2014),
1 August 2014
,
Page 147-149
https://doi.org/10.22037/aaem.v2i3.125
Abstract
The patient was a 23-year-old man referred to the emergency department (ED) with the chief complaint of palpitation. The patient experienced dizziness, cold sweating, and lightheadedness after getting up which started spontaneously. He had four episodes of the same problems in seven months ago that felt better after taking 10 mg propranolol. But, in the current episode his problem was not solved by the same medication. He had no history of smoking, substance abuse, medication use, congenital heart disease, syncope, previous surgery, chest trauma, or any other known medical problems. As well, he had no any positive history of the same problems in his family. The patients’ on-arrival vital signs were as follow: systolic blood pressure (SBP): 90 mmHg, pulse rate (PR): 150/minute, respiratory rate (RR): 14/minute, oral temperature: 37◦C, oxygen saturation 96% with nasal cannula and 100% oxygen, Glasgow coma scale (GCS) 15/15. He was not experienced any other concomitant problems such as ischemic chest discomfort, shortness of breathing, or sign of circulatory shock such as paleness, mottling, etc. On general physical examination the patients’ lung and heart sounds, four limbs pulses, and capillary refile were normal. As well, focused neurological and abdominal examinations did not have any positive finding. The patient underwent close cardiac, vital sign monitoring and electrocardiography (ECG). Figure 1 shows the on-arrival patients’ ECG. Atrial fibrillation (AF) was diagnosed by the corresponding physician and digoxin (!?) prescribed that led to severe lethargy, weakness, sweating, and bradycardia. Figure 2 shows the post mediation ECG of patient.How to Cite
References
Neumar RW, Otto CW, Link MS, et al. Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 suppl 3):S729-S67.
Hurst JW, Paulk Jr EA, Proctor HD, Schlant RC. Management of patients with atrial fibrillation. Am J Med. 1996;37(5):728-41.
Simonian SM, Lotfipour S, Wall C, Langdorf MI. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. Intern Emerg Med. 2010;5(5):421-6.
Kaushik M, Sharma M, Ganju N. Wolff-Parkinson-White syndrome presenting as atrial fibrillation with wide-QRS complexes. J Indian Acad Clin Med. 2003;4:152-55.
Değirmencioğu A, Karakuş G, Baysal E, Zencirci E, Çakmak N. A rare manifestation of atrial fibrillation in the presence of Wolff-Parkinson-White syndrome: tachycardia-induced cardiomyopathy. Turk Kardiyol Dern Ars. 2014;42(2):178-81.
Szumowski L, Orczykowski M, Derejko P, et al. Predictors of the atrial fibrillation occurrence in patients with Wolff-Parkinson-White syndrome. Kardiol Pol. 2009;67(9):973-8.
Levis J, Garmel G. Atrial fibrillation with Wolff-Parkinson-White syndrome. Internet J Emerg Med. 2008;5(1):1-3.
Szumowski Å, Walczak F, Urbanek P, et al. Risk factors of atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Kardiol Pol. 2004;60(3):206-16.
Hamada T, Hiraki T, Ikeda H, et al. Mechanisms for Atrial Fibrillation in Patients with Wolffâ€Parkinsonâ€White Syndrome. J Cardiovasc Electrophysiol. 2002;13(3):223-9.
- Abstract Viewed: 334 times
- PDF Downloaded: 3584 times